One of the strongest trends in clinical trials is patient centricity, which is to say, making the patient experience as easy and accessible as possible. During the height of the COVID-19 pandemic, this became even more of a focus because of limitations on patients visiting clinics and health care institutions for nonurgent care. This led to an increase in decentralized clinical trials (DCT),1 where some or all of a trial was conducted outside a trial site via telehealth visits, remote monitors/sensors, patient-reported outcomes and in-home visits. The trend has continued and emphasizes the importance of communicating with patients effectively and efficiently using a variety of modes, including print, email, texts, web-based portals and more.
